Latest News – PSNC Main site
Pharmaceutical Services Negotiating Committee
Briefing MPs on COVID-19 costs
PSNC is continuing its work to brief Parliamentarians on the financial pressures facing community pharmacies. Ahead of the Budget, PSNC had called upon the Chancellor to intervene in ongoing COVID-19 funding negotiations and ensure that pharmacies do not have to pay back the £370 million in emergency loans they received last year. The letter was...
Ventilation of indoor spaces to help stop the spread of coronavirus
New guidance has been published by the Department of Health and Social Care (DHSC) on how ventilation in the workplace can help to stop the spread of coronavirus (COVID-19). The guidance includes a short section on ‘workplace settings’ which explains the importance of identifying areas that are not well ventilated, gives examples of control measures...
No Smoking Day 2021
No Smoking Day is a national campaign that encourages the nation’s smokers to make a quit attempt on the second Wednesday of March each year. The day is an important opportunity to engage smokers in your local community, encouraging them to quit and access local stop smoking support. This year’s campaign has been developed collaboratively...
PEPS payments information
Contractors signed up to the Pharmacy Earlier Payments Scheme (PEPS) will have received their payments on 1 March directly from the NHS Business Services Authority (NHSBSA) instead of the finance company Greensill Capital. Contractors have been rightly concerned by the recent news reports regarding Greensill: given the more general parlous state of community pharmacy funding,...
Contractor Notice: SSP010 for Levothyroxine 12.5mcg extended
The Department of Health and Social Care (DHSC) has provided an update on the Serious Shortage Protocols (SSPs) for Levothyroxine 12.5mcg tablets (SSP010). SSP010 for Levothyroxine 12.5mcg tablets was previously expected to expire on 5th March 2021 but the end date has been further extended to 12th March 2021. Please note: expiry dates of an...
Supply Disruption Alert: Repaglinide 1mg and 2mg tablets
Department of Health and Social Care (DHSC) has issued a medicine supply disruption alert for Repaglinide 1mg and 2mg tablets Alert reference: SDA/2021/005 Viatris are currently out of stock of repaglinide 1mg and 2mg tablets until early May 2021 due to regulatory issues. Rivopharm UK Limited are out of stock due to manufacturing issues and...
Summary of the Integration and Innovation DHSC White Paper
On 11th February 2021, the Government published a White Paper – Integration and Innovation: working together to improve health and social care for all – setting out proposals for primary legislation which would make changes to the structure of the NHS in England. This PSNC Briefing provides a summary of the key points in the...
PSNC calls on Chancellor to write off pharmacies’ COVID loans
Ahead of today’s (3 March) Budget, PSNC has called on the Chancellor of the Exchequer to intervene in the ongoing COVID-19 funding negotiations and ensure that pharmacies do not have to pay back any of the £370m in emergency loans they received last year. Warning that paying back the loans could put many pharmacies at...
MHRA Class 3 Medicines Recall: Easyhaler Salbutamol Sulfate 100 & 200micrograms per actuation
Class 3 Medicines recall: Easyhaler Salbutamol Sulfate 100 & 200micrograms per actuation inhalation powder (Orion Corporation T/A Orion Pharma (UK) Ltd) Drug alert number: EL (21) A/06 Date issued: 1st March 2021 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 3 medicines recall for: Easyhaler Salbutamol Sulfate 100 & 200micrograms per...
Final Reminder: PQS Part 2 claim window closes today
Community pharmacy contractors have until 23:59 tonight to claim a payment for the Pharmacy Quality Scheme 2020/21 Part 2 Scheme as the window for claiming this payment closes. Contractors who wish to, can claim a PQS Part 2 payment for any domains they feel they have met and will have the evidence to support. The PQS...
PharmaTimes: PharmaTimes Website RSS
PharmaTimes - The latest news in healthcare and life sciences - PharmaTimes Website RSS
FDA to review Sanofi’s Dupixent in children with uncontrolled asthma
Sanofi is also planning an EU regulatory submission for Dupixent in the same indication
Lilly’s tirzepatide claims head-to-head trial win against injectable semaglutide
Tirzepatide demonstrated superior A1C and body weight reduction in type 2 diabetes
ClinSpec Diagnostics reaches funding target of £3.5m
University of Strathclyde spin-out is developing liquid biopsies for early cancer detection
Modified COVID-19 vaccines can avoid ‘lengthy’ clinical studies, says MHRA
UK’s regulatory authority will fast-track jabs modified to new variants
ConserV Bio partners with eTheRNA on mRNA vaccine development
Collaboration will focus on vaccines for infectious diseases
NICE rejects rare blood cancer treatment Poteligeo in final appraisal
Final appraisal document said that clinical trial evidence for Poteligeo is ‘very uncertain’
EMA launches rolling review of Russia’s Sputnik V COVID-19 vaccine
Rolling review begins based on lab and clinical studies in adults
Chancellor pledges an extra £1.65bn for UK’s COVID-19 vaccination roll-out
Budget 2021 also details new funding for UK life sciences companies and more
ERS Genomics signs CRISPR license agreement with Otsuka
License grants Otsuka access to CRISPR/Cas9 genome editing technology
Idorsia submits investigational insomnia treatment daridorexant to the EMA
Daridorexant is a dual orexin receptor agonist (DORA) designed for the treatment of insomnia
US court rules in favour of AZ in Symbicort patent litigation
Court decision rules against Mylan Pharmaceuticals and Kindeva Drug Delivery
NICE backs NHS use of Lilly’s Olumiant in eczema
Oral JAK inhibitor approved to treat moderate-to-severe atopic eczema in adults
Cosentyx gains EU approval for new label extension
Label update includes data for axial manifestations of psoriatic arthritis
NHS prescription charges set to rise in England
Charge will increase to £9.35 per single prescription item from 1 April 2021
NICE backs selective internal radiation therapy for advanced liver cancer
Hundreds of people will be able to benefit from this treatment type
Every sector of the pharmaceutical market is represented under one roof, this year in Madrid. Attending CPhI Worldwide is the most cost effective way to establish new business relationships, meet with global partners and stay updated on the latest industry trends.
Find out more: https://www.cphi.com/europe/